Risk of Microangiopathy in Patients with Epilepsy under Long-term Antiepileptic Drug Therapy
- PMID: 29593629
- PMCID: PMC5857530
- DOI: 10.3389/fneur.2018.00113
Risk of Microangiopathy in Patients with Epilepsy under Long-term Antiepileptic Drug Therapy
Abstract
Background: Long-term antiepileptic drug (AED) therapy is considered a risk factor of atherosclerosis. Furthermore, the duration of therapy contributes to acceleration of large-vessel atherosclerosis. Therefore, in this study, we tested the hypothesis that long-term AED therapy plays a crucial role in the pathogenesis of microangiopathy in patients with epilepsy.
Methods: We recruited 120 patients with epilepsy (age, 18-60 years) and 40 healthy controls. Optical coherence tomography (OCT) was used to measure the central macular thickness and diameters of the retinal artery and vein to evaluate atherosclerotic retinopathy; microalbumin and creatinine levels in urine were assessed to evaluate atherosclerotic nephropathy. In addition, high-sensitivity C-reactive protein (hs-CRP), lipid profiles, homocysteine, folate, uric acid, and body mass index were determined.
Results: The ratio of urine albumin to creatine and OCT findings showed that patients with epilepsy had higher abnormal microalbuminuria and narrowing retinal vein diameters, respectively. Multiple linear regression analysis showed that increased triglyceride and hs-CRP levels might contribute to microalbuminuria. In addition, serum creatinine, duration of AED therapy, enzyme-inducing AED therapy, and duration of enzyme-inducing AED therapy were candidate risk factors for retinal vein narrowing.
Conclusion: Patients with epilepsy are at a higher risk for microangiopathy presented as retinopathy and nephropathy. Long-term AED therapy, particularly with enzyme-inducing AEDs; high triglyceride levels, and inflammatory processes play an important role in the development of microangiopathy in patients with epilepsy.
Keywords: antiepileptic drug therapy; atherosclerosis; microalbuminuria; microangiopathy; retinopathy.
Similar articles
-
Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis.Epilepsia. 2012 Jan;53(1):120-8. doi: 10.1111/j.1528-1167.2011.03316.x. Epub 2011 Nov 15. Epilepsia. 2012. PMID: 22085257
-
Long-term antiepileptic drug therapy contributes to the acceleration of atherosclerosis.Epilepsia. 2009 Jun;50(6):1579-86. doi: 10.1111/j.1528-1167.2009.02024.x. Epub 2009 Mar 9. Epilepsia. 2009. PMID: 19292757 Clinical Trial.
-
Epilepsy and antiepileptic drugs: risk factors for atherosclerosis.Int J Neurosci. 2015;125(7):507-11. doi: 10.3109/00207454.2014.949704. Epub 2014 Aug 28. Int J Neurosci. 2015. PMID: 25164095
-
Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy.Epilepsy Behav. 2017 Nov;76:24-31. doi: 10.1016/j.yebeh.2017.08.039. Epub 2017 Sep 18. Epilepsy Behav. 2017. PMID: 28931473 Review.
-
The importance of drug interactions in epilepsy therapy.Epilepsia. 2002 Apr;43(4):365-85. doi: 10.1046/j.1528-1157.2002.13001.x. Epilepsia. 2002. PMID: 11952767 Review.
Cited by
-
Elevated Blood C-Reactive Protein Levels in Patients With Epilepsy: A Systematic Review and Meta-Analysis.Front Neurol. 2019 Sep 18;10:974. doi: 10.3389/fneur.2019.00974. eCollection 2019. Front Neurol. 2019. PMID: 31620066 Free PMC article.
-
Comparison of myocardial perfusion between the users of two antiepileptic medications: valproate vs. carbamazepine.Asia Ocean J Nucl Med Biol. 2023;11(2):122-127. doi: 10.22038/AOJNMB.2023.67084.1465. Asia Ocean J Nucl Med Biol. 2023. PMID: 37324229 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous